SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon shares are facing intense scrutiny following a Q4 report that featured a double earnings beat but was overshadowed by a significant, disappointing guidance cut. While the community is actively debating whether the stock is undervalued at current levels or if the brand is suffering from weakened demand and increased competition, the broader sentiment remains cautious as investors weigh potential leadership changes and long-term growth prospects against immediate margin pressures.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending as investors weigh a wave of regulatory progress, including recent DOE and NRC approvals, against the pressure of an upcoming earnings release. The community remains deeply polarized, with bulls focused on long-term data center partnerships and nuclear energy demand, while bears point to the company's pre-revenue status and significant insider selling as red flags.

Swarmer, Inc. is an AI-driven software company, which develops software platforms and AI systems for autonomous swarm control of drones and unmanned vehicles. The firm offers STYX AI Command and Control System, MINAS Autonomy and Collaboration AI, and TRIDENT Embedded Drone Operating System. The company was founded by Alex Fink and Serhii Kuprienko in May 2023 and is headquartered in Austin, TX.

Swarmer Inc.

Swarmer Inc. is generating significant market buzz following its recent IPO as retail investors flock to the drone and autonomous defense software provider. The community is actively debating its high-growth potential and low-float volatility, with many traders drawing parallels to other explosive defense-tech runners while tracking its performance amid ongoing global geopolitical instability.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently the center of active community debate following the filing for a new $1 billion at-the-market offering, which many investors are analyzing as a strategic move to bolster long-term funding despite recent volatility. While some participants express frustration over the timing of the announcement, others are framing the offering as a necessary step for capital-intensive growth, keeping the stock a major focal point for discussions on sector liquidity and future scaling.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital is currently experiencing significant volatility as investors closely monitor for updates regarding a potential anchor tenant and the scaling of their data center infrastructure. The community is actively debating the company's long-term potential versus concerns about leadership transparency, with many traders focused on volume patterns and the impact of speculative rotations in the AI-energy sector.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending as investors digest the company's update on the FLAMINGO-01 trial, which reported that commercially manufactured GP2 is now being utilized across all U.S. clinical sites. The community remains hyper-focused on the upcoming release of AACR abstract titles, interpreting the full Steering Committee's co-authorship as a major signal of scientific confidence and a potential precursor to a significant partnership or buyout.

DocuSign, Inc. engages in the provision of cloud-based electronic signature solutions, which helps companies and individuals securely collect information, automate data workflows, and sign anything. The firm automates manual and paper-based processes allowing users to manage all aspects of documented business transactions including identity management, authentication, digital signature, forms and data collection, collaboration, workflow automation, and storage. Its products include eSignature, CLM, Gen for Salesforce, Document Generation, Standards-Based Signatures, Notary and Web Forms. The company was founded by Thomas H. Gonser and Court Lorenzini in 2003 and is headquartered in San Francisco, CA.

DocuSign Inc

DocuSign shares are facing intense downward pressure as investors rotate out of the software sector, with many community members expressing frustration over consistent selling and concerns that generative AI could commoditize the firm's core digital agreement services. While some traders are attempting to buy the dip at multi-year lows, citing strong cash flow and potential short-squeeze opportunities, others remain skeptical about the stock's long-term competitive moat in an AI-dominated market.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is facing intense volatility as market participants debate a new short-seller report alleging accounting irregularities, which has triggered heavy trading volume and prompted a rapid V-shaped recovery attempt. While bears are pushing concerns over loan valuations and debt, long-term investors are actively buying the dip, bolstered by recent significant insider purchases from the CEO that have fueled speculation of an imminent squeeze.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital is catching investor attention as it rides a massive wave of AI-driven memory and storage demand, with shares benefiting from robust sector momentum and a substantial new share buyback program. While some traders are expressing caution regarding potential volatility and valuation concerns, the community is actively debating whether the current rally represents a long-term breakout or a temporary peak ahead of further industry growth.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

Fannie Mae ($FNMA) is trending as investors debate the impact of potential legislative hurdles and ongoing conservatorship, with community sentiment sharply divided between those viewing current volatility as a buying opportunity and others frustrated by a lack of progress toward an IPO. The discussion is heavily centered on whether administration officials or Congressional action will serve as the primary catalyst for an eventual exit from government control.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Atea Pharmaceuticals (NASDAQ:AVIR) Hits New 12-Month High - Here's Why

Atea Pharmaceuticals (NASDAQ:AVIR) Hits New 1-Year High - What's Next...

Atea Pharmaceuticals Q4 Earnings Call Highlights

Atea Pharmaceuticals (NASDAQ:AVIR) outlined progress in its hepatitis C (HCV) late-stage development program and provided an update on its newly expanded hepatitis E virus (HEV) pipeline during its...

Atea Pharmaceuticals (NASDAQ:AVIR) Posts Earnings Results, Misses Expectations By $0.08 EPS

Atea Pharmaceuticals (NASDAQ:AVIR - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.57) earnings per share for the quarter, missing analysts' consensus...

Insights Ahead: Atea Pharmaceuticals's Quarterly Earnings

Atea Pharmaceuticals (AVIR) to Release Quarterly Earnings on Thursday

Atea Pharmaceuticals (NASDAQ:AVIR) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 5. (View Earnings Report at...

Atea Pharmaceuticals (NASDAQ:AVIR) Shares Down 2% - Here's What Happened

Atea Pharmaceuticals (NASDAQ:AVIR) Stock Price Down 2% - Here's Why...

Atea Pharmaceuticals (NASDAQ:AVIR) Trading Down 2% - Time to Sell?

Atea Pharmaceuticals (NASDAQ:AVIR) Trading Down 2% - Should You Sell...

Atea Pharmaceuticals Highlights Phase 3 HCV Timeline, Unveils New Hepatitis E Candidate AT-587 at JPMorgan Conference

Atea Pharmaceuticals (NASDAQ:AVIR) used its presentation at the 44th Annual JPMorgan Healthcare Conference to provide updates on its global Phase 3 program for hepatitis C (HCV) and to outline early...

Atea Pharmaceuticals (NASDAQ:AVIR) Stock Price Down 1.4% - Here's What Happened

Atea Pharmaceuticals (NASDAQ:AVIR) Trading Down 1.4% - Here's What Happened...

Atea Pharmaceuticals (NASDAQ:AVIR) Trading Down 1.9% - Should You Sell?

Atea Pharmaceuticals (NASDAQ:AVIR) Stock Price Down 1.9% - Should You Sell...

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.56	--	--	N/A
Q4 '25	-$0.49	-$0.57	-17.53%	MISSED
Q3 '25	-$0.41	-$0.53	-27.71%	MISSED
Q2 '25	-$0.41	-$0.44	-6.02%	MISSED
Q1 '25	-$0.50	-$0.40	20.53%	BEAT

AVIR
Atea Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest AVIR News

AVIRAtea Pharmaceuticals Inc